论文部分内容阅读
目的观察经导管肝动脉化疗栓塞术(TACE)治疗中晚期原发性肝癌的疗效。方法采用Seldinger技术,经股动脉穿剌,选择性肝动脉插管灌注化疗联合碘油栓塞(部分病例加用明胶海绵)治疗中晚期原发性肝癌患者中随机选择60例,共行140次介入治疗。结果显效60%(36/60),有效31.7%(19/60),稳定8.7%(5/60),生存率显著提高,12个月以上生存率达63.3%(38/60)。结论TACE治疗中晚期原发性肝癌疗效确切,能够显著延长生存期,提高生存质量。
Objective To observe the efficacy of transcatheter hepatic arterial chemoembolization (TACE) in the treatment of advanced primary liver cancer. Methods Seldinger technique was used to select 60 patients randomly during the treatment of advanced primary liver cancer by selective perfusion of femoral artery and selective hepatic arterial infusion chemotherapy combined with lipiodol embolization (some cases plus gelatin sponge) treatment. The results were 60% (36/60), 31.7% (19/60), stable 8.7% (5/60), the survival rate was significantly increased, and the survival rate was 63.3% (38/60) after 12 months. Conclusion TACE treatment of advanced primary liver cancer curative effect is exact, can significantly prolong survival and improve quality of life.